Catastrophic expenditure and impoverishment of patients affected by 7 rare diseases in China

Abstract

BackgroundChina is actively promoting regulation of rare diseases, rare disease and orphan drugs have been formally incorporated into the national planning. However, few studies have been done to evaluate the affordability of rare disease patients in China. This study aims to provide policy recommendations for the establishment of social security mechanism for rare diseases in China, so as to address the problem of poverty caused by these diseases.MethodsA total of 7 rare diseases were selected by Delphi method. Affordability of treatment for the 7 rare diseases was assessed through annual per capital income, catastrophic expenditure and impoverishment expenditure among urban and rural residents in China.ResultsAssessed through annual per capital income, health expenditure for the 7 rare diseases are all rather high. The highest health expenditure is equivalent to income of 69.34 years of one urban resident, and the burden is heavier for rural residents. Through catastrophic expenditure assessment, proportions of the population experiencing catastrophic expenditure caused by the 7 rare diseases are all under 0.167 ‰. However, once one is ill and taking medications, he will suffer from catastrophic health expenditure. Through impoverishment expenditure assessment, the proportions of impoverishment payment are low among both urban and rural residents, but the 7 rare diseases could lead nearly 4.6 million people into poverty on a national scale.ConclusionThe affordability of treatment for rare disease as well as orphan drugs is rather poor. Residents of different income levels all have difficulties to afford the treatment for rare diseases, so poverty caused by rare diseases is quite widespread. Therefore, social security mechanism for rare disease patients should be established and specific payment pattern for orphan drugs should be set up.Electronic supplementary materialThe online version of this article (doi:10.1186/s13023-016-0454-7) contains supplementary material, which is available to authorized users.

How Do Patients and Doctors Perceive Medical Services for Rare Diseases Differently in China? Insights from Two National Surveys

“…Both doctors and patients in this study believed that lack of affordability was a big obstacle in treating rare diseases. Previous studies by Dong and Xin have shown that patients with rare diseases in China encounter very high medical costs and unaffordable financial burdens [ 15 , 16 ]. A survey by Bin et al also found the average annual medical expenditure of patients affected by seven rare diseases in Fujian Province to be USD 15,575, with the maximum being USD 314,353, in 2015.…”

“…Dong and Wang’s (2016) study reported that the medical expenditure of an individual with a rare disease was three times higher than his/her individual income and 1.9 times higher than his/her family income [ 15 ]. Xin et al also estimated that nearly 4.6 million individuals in China suffered from poverty because of their rare conditions [ 16 ].…”

The Tsinghua–Lancet Commission on Healthy Cities in China: unlocking the power of cities for a healthy China

“…It was estimated that, at a national scale, 247 620 urban residents could be lowered into poverty because of the medical cost caused by seven rare diseases in 2014. 275 The uneven results are mostly caused by the decentralised and incremental approach to universal health coverage in China. The varied financing capacity of local governments leads to high variability of benefit packages for health insurance.…”

Analysis of the Situation of Unmet Health Care Need Among Extremely Rare Disease of Gaucher

“…By measuring the economic and care burdens of diseases to the society will facilitate a prioritized healthcare policies and strategies [1]. However, evidence on the nancial burden (e.g., direct medical costs, direct nonmedical costs, and indirect costs) associated with GD in China is limited [16,17]. Extensive health care needs and frequent medical care and expenses are associated with the economic burden of patients and caregivers [18].…”